SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000244
Filing Date
2022-03-01
Accepted
2022-03-01 12:48:43
Documents
80
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nwbo-20211231x10k.htm   iXBRL 10-K 2867602
2 EX-10.86 nwbo-20211231xex10d86.htm EX-10.86 159395
3 EX-10.87 nwbo-20211231xex10d87.htm EX-10.87 54915
4 EX-23.1 nwbo-20211231xex23d1.htm EX-23.1 3618
5 EX-31.1 nwbo-20211231xex31d1.htm EX-31.1 17799
6 EX-32.1 nwbo-20211231xex32d1.htm EX-32.1 10929
7 GRAPHIC nwbo-20211231x10k001.jpg GRAPHIC 38207
  Complete submission text file 0001410578-22-000244.txt   13558285

Data Files

Seq Description Document Type Size
8 EX-101.SCH nwbo-20211231.xsd EX-101.SCH 89799
9 EX-101.CAL nwbo-20211231_cal.xml EX-101.CAL 69734
10 EX-101.DEF nwbo-20211231_def.xml EX-101.DEF 372006
11 EX-101.LAB nwbo-20211231_lab.xml EX-101.LAB 614621
12 EX-101.PRE nwbo-20211231_pre.xml EX-101.PRE 557684
74 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20211231x10k_htm.xml XML 2793472
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 22695773
SIC: 2834 Pharmaceutical Preparations